avandiaDiabetes Drug Avandia Unavailable in Retail Pharmacies after November
Avandia, the controversial diabetes drug introduced by GlaxoSmithKline in 1999, will no longer be available in retail pharmacies after this November. The FDA announced in September that it would take this action after a study showed Avandia was associated with increased cardiovascular risks. New rules governing the distribution and prescription of Avandia are now being announced. In a 2007 study, cardiologist Dr. Steven Nissen found that Avandia caused a 40 percent increase in the risk of cardiovascular disease, heart attack, …
Life After Avandia: New Diabetes Drugs Will Face Tougher Testing for Heart-Failure Risks
In the wake of widespread reports of heart failures, liver damage, and other patient injuries and seemingly non-stop controversy surrounding the top-selling type-2 diabetes drug Avandia, the Food and Drug Administration now says that future diabetes drugs will face much tougher scrutiny.
Avandia: Popular Diabetes Drug Linked to Fatal Heart Attacks
Avandia, the blockbuster type 2 diabetes drug taken by an estimated six million Americans, has been linked to an increased risk of heart attack and cardiovascular death. Avandia was approved in 1999 for the treatment of type 2, or adult onset, diabetes, which affects an estimated 18 to 20 million Americans and is a leading cause of coronary heart disease, blindness, kidney failure, and limb amputation. Diabetes occurs when the body either does not produce enough insulin or is insensitive …
Elderly Diabetics Face Increased Heart Attack Risks from Avandia, Study Finds
Elderly patients who took the controversial anti-diabetes drug Avandia were more likely to suffer deadly congestive heart failure than patients who took a similar drug, a new study has found. Researchers at Harvard Medical School tracked 28,361 diabetes patients for five years. Roughly half of the patients were treated with Avandia (generic rosiglitazone) while half received a competing drug, Actos (generic pioglitazone). Researchers found that Avandia patients were 15 percent more likely to die and 13 percent more likely to …
facebook
rss
twitter